Stock listing

NASDAQ:NGM NGM Biopharmaceuticals Inc Stock

Follow NGM Biopharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:NGM

$1.54 USD

Close on Apr 8, 2024 · No longer trades

Apr 4, 2019 to last close -89.5% · weekly closes, Apr 4, 2019 – Apr 8, 2024
Lowest – highest close
$0.60 – $31.93 USDSince Apr 4, 2019 · lowest Nov 17, 2023 · highest Mar 17, 2021

Delisted NASDAQ:NGM no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:NGM
Asset type
Stock
Exchange
NASDAQ
Currency
USD

NGM Biopharmaceuticals Inc on 6ix

Decks
1 deck · latest Jan 13, 2020

Decks

DeckKindSlidesDate
Investor Presentation (January 2020)Investor deck36 slidesJan 13, 2020

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Carole Ho
Other companies: Eli Lilly and Company (Executive Vice President and President, Lilly Neuroscience · Since at least Dec 31, 2025); Royalty Pharma plc (Director · Since at least Jul 17, 2025); Beam Therapeutics Inc. (Director · Since at least Feb 5, 2020); Denali Therapeutics Inc. (Chief Medical Officer · Since at least Apr 1, 2019)
Director · Jun 5, 2020 – Apr 5, 2024 · Past
Peter Svennilson
Other companies: RAPT Therapeutics Inc (Director · Jun 18, 2020 – May 28, 2021 · Past); Revolution Medicines, Inc. (Director · Jun 17, 2020 – Apr 26, 2021 · Past); ORIC Pharmaceuticals, Inc. (Director · Apr 23, 2020 – Jun 16, 2021 · Past); Gritstone bio, Inc. (Director · Jun 19, 2019 – Jun 19, 2019 · Past)
Director · Apr 3, 2019 – Apr 8, 2020 · Past
William Rieflin
Other companies: Lyell Immunopharma, Inc. (Director · Since at least Jun 16, 2021); RAPT Therapeutics Inc (Director · Oct 30, 2019 – May 22, 2024 · Past); XenoPort Inc (Director · May 17, 2016 – Jul 5, 2016 · Past)
Director · Apr 3, 2019 – Apr 5, 2024 · Past
Mangini Siobhan Nolan
Other companies: Alight, Inc. (Director · Since at least Jan 1, 2024); Castlight Health Inc (President · Jul 8, 2016 – Feb 16, 2020 · Past)
President and CFO · Jul 13, 2020 – Mar 2, 2023 · Past
Suzanne Sawochka Hooper
Other companies: Eidos Therapeutics Inc (Director · Aug 6, 2020 – Jan 26, 2021 · Past); Jazz Pharmaceuticals plc (EVP & General Counsel · Mar 12, 2012 – Feb 25, 2019 · Past)
Director · Apr 3, 2019 – Apr 5, 2024 · Past
David J. Woodhouse
Other companies: Surrozen, Inc. (Chairman of the Board · Since at least Aug 11, 2021)
Chief Executive Officer, Director · Apr 3, 2019 – Apr 5, 2024 · Past
David Schnell
Other companies: Kythera Biopharmaceuticals Inc (Director · Oct 10, 2012 – Jun 5, 2014 · Past)
Director · Apr 3, 2019 – May 20, 2020 · Past
McHenry T Tichenor
Other companies: Belo Corp (Director · Aug 3, 2009 – Dec 31, 2013 · Past)
Director · Apr 3, 2019 – May 20, 2020 · Past
Roger Perlmutter
Other companies: Eikon Therapeutics, Inc. (See remarks, Director · Since at least Feb 4, 2026)
Director · May 18, 2022 – Apr 5, 2024 · Past
Valerie L Pierce
Other companies: Sunesis Pharmaceuticals Inc (SVP & General Counsel · Apr 16, 2007 – Jun 30, 2008 · Past)
See Remarks · Mar 3, 2021 – Mar 26, 2024 · Past
All 12 people
PersonSeat
Hsiao D LieuChief Medical Officer · Mar 11, 2020 – Apr 5, 2024 · Past
Irene PerlichPrincipal Accounting Officer · Sep 15, 2023 – Apr 5, 2024 · Past

Open People

Log in to ask 6ix AI your own questions about NGM Biopharmaceuticals Inc.